AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Elanco Animal Health Incorporated (ELAN)

AMNEAL PHARMACEUTICALS, INC. and Elanco Animal Health Incorporated are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.2B against $6.3B — 1.8× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; AMNEAL PHARMACEUTICALS, INC. trades at 39.5×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 9.28%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (5.05% vs −3.96%) and the higher return on invested capital (11.1% vs 0.51%). Across the 20 metrics below, AMNEAL PHARMACEUTICALS, INC. leads on 12 and Elanco Animal Health Incorporated on 8.

Valuation

Metric AMRX ELAN Drug Manufacturers Specialty & Generic median
P/E 39.54 n/m 20.14
P/S 2.02 2.22 2.25
P/B 191.09 1.69 1.90
Price to free cash flow n/m 31.22 16.54
EV/EBITDA 13.30 18.78 12.29
EV/Sales 2.84 2.89 2.56
Earnings yield 2.53% (1.84%) (2.99%)
Free cash flow yield (0.18%) 3.20% 0.00%

Profitability

Metric AMRX ELAN Drug Manufacturers Specialty & Generic median
Gross margin 39.32% 55.36% 53.94%
Operating margin 14.56% 1.61% 0.00%
Net margin 5.05% (3.96%) 0.00%
Free cash flow margin (0.37%) 7.55% 0.00%
Return on equity (395.84%) (2.98%) (0.40%)
Return on assets 4.37% (1.46%) (3.32%)
Return on invested capital 11.05% 0.51% 0.00%

Growth

Metric AMRX ELAN Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 9.28% 11.95% 10.01%
EPS growth (last fiscal year) 157.89% (169.12%) —
Revenue growth, 5-year CAGR 8.66% 7.59% 6.74%
Net income growth, 5-year CAGR (4.57%) 0.00% 0.00%

Health

Metric AMRX ELAN Drug Manufacturers Specialty & Generic median
Debt to equity 80.86 0.59 0.05
Current ratio 2.20 2.05 2.31
Net debt to EBITDA 3.62 5.00 0.85

Dividend

Metric AMRX ELAN Drug Manufacturers Specialty & Generic median
Dividend yield 0.27% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AMRX ELAN Drug Manufacturers Specialty & Generic median
Market cap 6.32b 11.21b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack